2023 was a tough 12 months for your biopharma market, with several corporations downsizing and restructuring their workforces to stay afloat. There are signs of recovery, as mergers and acquisitions picked up over the pharmaceutical and life sciences industry within the latter A part of 2023 and possess continued their https://sites.google.com/view/bio-sites/blog